Connect with us

News

Is The THC % Game Rigged?

Published

on

Is The THC % Game Rigged?

Go to almost any dispensary today and you will hear it: “This is 32%.” Budnenders Pitch Flower with a high thc high level, as if it is golden nuggets, consumers are in a hurry to grab banks with the highest number, and the plaster brands are like an honorary sign. In today’s market, the percentage of potentials are not just a selling point – they have become the entire cannabis personality.

But here’s the problem: the percent of Thc is one of the most deceptive and manipulated indicators in the field. Consumers believe that this is the highest quality measure, manufacturers feel pressure to multiply, except for numbers, and laboratories are under fire for inflating results. Truth is more ugly than most, and it rebuilds the cannabis future ways that can leave everyone worse.

Why do consumers pursue thc

Legalization led cannabis in the mainstream, but it also brought it to a mathematical problem: more thc = the best weed. For new consumers, especially those who are accustomed to the scale, the largest number on the bank feels like the safest rate. Why pay for a flower, indicated by 18% when 32% of the strain promises “almost twice as much as durability”?

Veterans know better. Anyone who has long been, knows that 17% deformation can knock you down, while 30% bud feels amazing. All because cannabis is not the only compound; This is a whole ecosystem, and each item works together to create balance and consequences. Cannabinoids, Terpens and flavonoids play together to create “high”. This is known as an entourage effect, and it often matters much more than the raw Thc content.

However, the customers of the dispensary strengthen the fixation. Many often refuse a spare flower when it tests below 25%, no matter how fragrant or unique. Manufacturers know this, and many admit that they feel the numbers to stay on the shelves.

Read the rest of this article about High Times, Click here

Message Or falsified the game thc %? appeared first further Retail Marijuana Retail Report – News and Information for Cannabis sellers.

(Tagstotranslate) Thc

Featured

Marijuana Retail Report

Published

on

By

Marijuana Retail Report



Everyone is on the edge of their seats

yesterday afternoon Washington Post and other sources report that President Trump is expected to issue an executive order directing federal agencies to reclassify marijuana as Schedule III. It’s some sexy reporting, though WaPo sources cautioned that “Trump could still change his mind” and “(a) White House official said no final decisions have been made on moving marijuana.”

That said, this is a story with legs, and I want to get back to some important points – aside from my usual refrain that marijuana shouldn’t be scheduled at all. Here are some important points to understand about a potential move to Schedule III.

Trump has options for moving marijuana

A WaPo story reports that an executive order may be in the cards. More likely – and depending on the content of the order – it will lead to a more direct, decisive approach than a formal one.”statement” and “request” released by President Biden in October 2022, which brought the redistricting process to a halt.

In August of this year, when Trump told reporters that his administration was considering moving marijuana, I laid out the following options:

  1. resume the stalled rulemaking process, adopt last year’s proposal to list marijuana in Schedule III;
  2. begin a new rulemaking process, presumably with a new proposed rule; or
  3. do away with rulemaking hearings entirely and the DOJ simply publishes a final rule listing marijuana in Schedule III (or wherever); or
  4. do nothing. Say, “We like marijuana where it’s at, science and treaties be damned.”

I noted:

One thing to address from the outset is the oft-repeated fiction that Trump could simply restore or repeal marijuana on his own via executive order. He can’t. However, he could lead the process in the same way that Biden did when Biden issued a request in 2022 that ordered HHS to review the controlled status of marijuana. Basically, Trump can say whatever he wants to see happen, and it’s likely to happen — especially given the strict loyalty the Justice Department has shown to him.

By this point, my colleague Jason Adelstone had arrived persuasive argument for the fifth option, which is that Trump could rely on Attorney General Pam Bondi to move marijuana on his own, even without rulemaking, under 21 USC § 811(d)(1). Jason concluded that “all it would take is a press release and a pen.”

Given the novelty of that approach, it is a given Prohibitionist Bondisuch a result would surprise me. In my previous post, I advocated for Option #3, which is the publication of the DOJ final rule. I explained:

Marijuana can then move to Schedule III (or wherever) within 30 or 60 days of the rules being published. Of course, people can appeal this rule. However, given the strength of the HHS findings and the apparent legal authority behind the Justice Department, it seems like an uphill battle.

I hope this is the chosen path and the administration will learn a lesson numerous, predictable errors former President Biden, DOJ Merrick Garland, and the Department of Anti-Ann Milgram when that administration made its failed foray into Schedule III.

The legal cannabis industry has benefited the most from marijuana’s transition

Schedule III was something of a holy grail for the cannabis industry, primarily because marijuana businesses would finally be taxed like other businesses. I explained:

When marijuana falls into Schedule III, the margin destruction statute, known as IRC § 280E will not apply and the cannabis industry will be changed forever. At the same time, the taxation of cannabis at the state level will not change. Or it could change for the worse if states feel emboldened to raise taxes on hemp in the absence of § 280E.

. . . .

However, I cannot stress enough that removing § 280E would change the industry forever. Having worked with cannabis companies for 13 years, I see taxation as the biggest insult to marijuana businesses – more than access to banking, intellectual property coverage, no bankruptcy, whatever. That would be HUGE.

Five things Schedule III won’t fix

We would like to remind people that Schedule III marijuana is not a one-size-fits-all solution. Here are five of the most persistent problems, in my opinion:

Criminal penalties for individuals. Possession, distribution and sale of non-FDA and non-hemp cannabis will still be criminal acts. State and local laws will not be violated in any way. We could see another 200,000 local arrestsannually, surrounded by List III.

Business headache. Like end users, state-licensed cannabis businesses would not theoretically be immune from federal prosecution. In addition, they will remain embargoed by the bankruptcy courts, will continue to fight over trademarks, and will still pay a premium for many shared services. Moreover, the intensive government regulation to which they are subject is unlikely to ease.

Banking issues. This is related to the above, and although banking it’s not the headache it used to beit still hurts. Schedule III marijuana would still be a controlled substance, and state-licensed businesses would still be “dealing” in that controlled substance, which is against federal law. Banks will continue to struggle with these dynamics.

Headache research. Contrary to popular belieffederal research won’t get any easier without significant intervention from Congress and administrations. It’s really a puzzle, but that’s our prediction.

Hemp. The industry of hop products from hemp took a big kick in the shorts last month when Congress passed PL 119-37. Most of these products will not survive the new law. The state-legal marijuana industry will benefit from less competition, and if marijuana becomes Schedule III, those operators will be less likely to lobby the hemp crowd for a “one-size-fits-all” federal hemp policy.

Schedule III Marijuana – Completion

I hope this happens and Christmas comes early for all our industry customers. However, I am cautious after viewing and to write about the rumor of carrying marijuana for most of the decade.

Source: Legal Canna Blog

Continue Reading

Canopy Growth

Marijuana Retail Report

Published

on

By

Marijuana Retail Report



MTL was founded by brothers Richard and Michel Clément from Quebec

Canopy Growth Corp. and MTL Cannabis Corp. announced that they have entered into a definitive agreement under which Canopy Growth will acquire all of the issued and outstanding common shares of MTL and settle all of the debt and debt instruments owed by MTL in a transaction valued at approximately $125 million on an all-equity basis and approximately $179 million on an enterprise value (TEV) basis.

Under the terms of the agreement, each MTL shareholder will receive a fixed consideration for each MTL share equal to: (i) 0.32 of a Canopy Growth common share (each whole share, a “Canopy Growth Share”) and (ii) $0.144 in cash.

MTL was founded by Quebec entrepreneurs and brothers Richard and Michel Clément, who built the company around a deep commitment to growing high-quality cannabis flowers. The quality of cannabis products produced through MTL’s disciplined, artisan approach to growing has earned national recognition, including being named Canada’s #1 recommended brand by enthusiasts in the Brightfield 2024 study.1. MTL provides proven operational excellence, loyal customer demand and experience in producing cannabis that works for the market. Canopy Growth intends to leverage the expertise of the MTL team as it continues to expand its line of cannabis products.

“MTL offers skilled operators, strong brands and a profitable business that will strengthen our leadership in the Canadian medical market and deepen our presence in key Canadian adult markets, including Quebec,” said Canopy Growth CEO Luc Mangeau. “Their growing experience combined with our national scale allows us to improve product quality, expand supply and accelerate our path to profitable growth. Together, we are building a stronger and more competitive Canadian business for the long term.”

“MTL was built on the idea that high-quality flowers, grown with care and consistency, will always earn the trust of consumers and patients,” said MLT Cannabis Co-Founder and Chief Cultivation Officer Richard Cleman. “Joining Canopy Growth gives us a platform to bring this philosophy to more Canadians. Our respective portfolios are very complementary and we see a great opportunity to expand MTL’s reach through Canopy Growth’s national distribution and retail relationships. We are incredibly proud of what our team has built and look forward to working with Canopy Growth to continue to elevate Canadian cannabis.”

Key transaction points are available for agreement here.

1 Recognized as Canada’s #1 Budtender Recommended Brand in the Brightfield 2024 Study, Brightfield Group, Canadian Budtender Study 2024 (in partnership with O2O). Findings based on a survey of ~670 Canadian youth in several Canadian provinces.

Continue Reading

Law

Marijuana Retail Report

Published

on

By

Marijuana Retail Report


News




Canna Provisions et al v. Bondi will refocus on the White House

US Supreme Court on Monday declined to hear the challenge of federal marijuana laws adopted by four licensed cannabis companies, including major marijuana operators in various states.

Supreme Court rejection of Canna Provisions and others v. Bondi refocuses attention on the white house and President Donald Trump’s Interest in Transmigrating Marijuana as the legal industry’s next great hope for major $32 billion reform.

Josh Schiller, a partner at the law firm Boies Schiller and one of the attorneys representing the plaintiffs, did not immediately respond to a request for comment.

A spokesperson for Verano Holding Corp., one of four licensed cannabis companies which originally sued the Department of Justice in October 2023did not immediately respond to a request for comment.

To read the rest of this article on MJ Biz Daily, Click here

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media